PPAP Automotive Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: October 10, 2025, 10:57 pm

Competitors of PPAP Automotive Ltd

All Competitor Stocks of PPAP Automotive Ltd

Quarterly Result

Last Updated: August 20, 2025, 5:20 am

Below is a detailed analysis of the quarterly data for PPAP Automotive Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 116.63 Cr.. The value appears to be declining and may need further review. It has decreased from 147.22 Cr. (Mar 2025) to 116.63 Cr., marking a decrease of 30.59 Cr..
• For Expenses, as of Jun 2025, the value is 107.33 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 132.22 Cr. (Mar 2025) to 107.33 Cr., marking a decrease of 24.89 Cr..
• For Operating Profit, as of Jun 2025, the value is 9.30 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Mar 2025) to 9.30 Cr., marking a decrease of 5.70 Cr..
• For OPM %, as of Jun 2025, the value is 7.97%. The value appears to be declining and may need further review. It has decreased from 10.19% (Mar 2025) to 7.97%, marking a decrease of 2.22%.
• For Other Income, as of Jun 2025, the value is 0.53 Cr.. The value appears to be declining and may need further review. It has decreased from 0.85 Cr. (Mar 2025) to 0.53 Cr., marking a decrease of 0.32 Cr..
• For Interest, as of Jun 2025, the value is 4.26 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.37 Cr. (Mar 2025) to 4.26 Cr., marking a decrease of 0.11 Cr..
• For Depreciation, as of Jun 2025, the value is 8.50 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.50 Cr..
• For Profit before tax, as of Jun 2025, the value is -2.93 Cr.. The value appears to be declining and may need further review. It has decreased from 2.98 Cr. (Mar 2025) to -2.93 Cr., marking a decrease of 5.91 Cr..
• For Tax %, as of Jun 2025, the value is -22.53%. The value appears to be improving (decreasing) as expected. It has decreased from 18.79% (Mar 2025) to -22.53%, marking a decrease of 41.32%.
• For Net Profit, as of Jun 2025, the value is -2.27 Cr.. The value appears to be declining and may need further review. It has decreased from 2.42 Cr. (Mar 2025) to -2.27 Cr., marking a decrease of 4.69 Cr..
• For EPS in Rs, as of Jun 2025, the value is -1.61. The value appears to be declining and may need further review. It has decreased from 1.72 (Mar 2025) to -1.61, marking a decrease of 3.33.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: August 23, 2025, 2:16 pm

Growth

Last Updated: September 5, 2025, 12:25 pm

Balance Sheet

Last Updated: September 10, 2025, 2:16 pm

Below is a detailed analysis of the balance sheet data for PPAP Automotive Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 14.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 14.00 Cr..
• For Reserves, as of Mar 2025, the value is 274.00 Cr.. The value appears strong and on an upward trend. It has increased from 269.00 Cr. (Mar 2024) to 274.00 Cr., marking an increase of 5.00 Cr..
• For Borrowings, as of Mar 2025, the value is 175.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 162.00 Cr. (Mar 2024) to 175.00 Cr., marking an increase of 13.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 105.00 Cr.. The value appears to be improving (decreasing). It has decreased from 110.00 Cr. (Mar 2024) to 105.00 Cr., marking a decrease of 5.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 568.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 556.00 Cr. (Mar 2024) to 568.00 Cr., marking an increase of 12.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 316.00 Cr.. The value appears strong and on an upward trend. It has increased from 313.00 Cr. (Mar 2024) to 316.00 Cr., marking an increase of 3.00 Cr..
• For CWIP, as of Mar 2025, the value is 27.00 Cr.. The value appears strong and on an upward trend. It has increased from 17.00 Cr. (Mar 2024) to 27.00 Cr., marking an increase of 10.00 Cr..
• For Investments, as of Mar 2025, the value is 44.00 Cr.. The value appears strong and on an upward trend. It has increased from 43.00 Cr. (Mar 2024) to 44.00 Cr., marking an increase of 1.00 Cr..
• For Other Assets, as of Mar 2025, the value is 181.00 Cr.. The value appears to be declining and may need further review. It has decreased from 183.00 Cr. (Mar 2024) to 181.00 Cr., marking a decrease of 2.00 Cr..
• For Total Assets, as of Mar 2025, the value is 568.00 Cr.. The value appears strong and on an upward trend. It has increased from 556.00 Cr. (Mar 2024) to 568.00 Cr., marking an increase of 12.00 Cr..

Notably, the Reserves (274.00 Cr.) exceed the Borrowings (175.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for PPAP Automotive Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 4.97. This value is below the healthy minimum of 5. It has increased from -9.31 (Mar 24) to 4.97, marking an increase of 14.28.
• For Diluted EPS (Rs.), as of Mar 25, the value is 4.95. This value is below the healthy minimum of 5. It has increased from -9.31 (Mar 24) to 4.95, marking an increase of 14.26.
• For Cash EPS (Rs.), as of Mar 25, the value is 28.53. This value is within the healthy range. It has increased from 15.54 (Mar 24) to 28.53, marking an increase of 12.99.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 204.38. It has increased from 202.07 (Mar 24) to 204.38, marking an increase of 2.31.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 204.38. It has increased from 202.07 (Mar 24) to 204.38, marking an increase of 2.31.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 393.29. It has increased from 373.51 (Mar 24) to 393.29, marking an increase of 19.78.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 41.51. This value is within the healthy range. It has increased from 29.57 (Mar 24) to 41.51, marking an increase of 11.94.
• For PBIT / Share (Rs.), as of Mar 25, the value is 17.06. This value is within the healthy range. It has increased from 5.19 (Mar 24) to 17.06, marking an increase of 11.87.
• For PBT / Share (Rs.), as of Mar 25, the value is 5.40. This value is within the healthy range. It has increased from -5.29 (Mar 24) to 5.40, marking an increase of 10.69.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 4.08. This value is within the healthy range. It has increased from -8.85 (Mar 24) to 4.08, marking an increase of 12.93.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 4.97. This value is within the healthy range. It has increased from -9.31 (Mar 24) to 4.97, marking an increase of 14.28.
• For PBDIT Margin (%), as of Mar 25, the value is 10.55. This value is within the healthy range. It has increased from 7.91 (Mar 24) to 10.55, marking an increase of 2.64.
• For PBIT Margin (%), as of Mar 25, the value is 4.33. This value is below the healthy minimum of 10. It has increased from 1.38 (Mar 24) to 4.33, marking an increase of 2.95.
• For PBT Margin (%), as of Mar 25, the value is 1.37. This value is below the healthy minimum of 10. It has increased from -1.41 (Mar 24) to 1.37, marking an increase of 2.78.
• For Net Profit Margin (%), as of Mar 25, the value is 1.03. This value is below the healthy minimum of 5. It has increased from -2.37 (Mar 24) to 1.03, marking an increase of 3.40.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.26. This value is below the healthy minimum of 8. It has increased from -2.49 (Mar 24) to 1.26, marking an increase of 3.75.
• For Return on Networth / Equity (%), as of Mar 25, the value is 2.43. This value is below the healthy minimum of 15. It has increased from -4.60 (Mar 24) to 2.43, marking an increase of 7.03.
• For Return on Capital Employeed (%), as of Mar 25, the value is 6.51. This value is below the healthy minimum of 10. It has increased from 1.94 (Mar 24) to 6.51, marking an increase of 4.57.
• For Return On Assets (%), as of Mar 25, the value is 1.23. This value is below the healthy minimum of 5. It has increased from -2.34 (Mar 24) to 1.23, marking an increase of 3.57.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.21. This value is within the healthy range. It has decreased from 0.26 (Mar 24) to 0.21, marking a decrease of 0.05.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.57. This value is within the healthy range. It has increased from 0.56 (Mar 24) to 0.57, marking an increase of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.98. It has increased from 0.94 (Mar 24) to 0.98, marking an increase of 0.04.
• For Current Ratio (X), as of Mar 25, the value is 0.88. This value is below the healthy minimum of 1.5. It has decreased from 0.94 (Mar 24) to 0.88, marking a decrease of 0.06.
• For Quick Ratio (X), as of Mar 25, the value is 0.57. This value is below the healthy minimum of 1. It has increased from 0.56 (Mar 24) to 0.57, marking an increase of 0.01.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.69. This value is within the healthy range. It has increased from 4.20 (Mar 24) to 4.69, marking an increase of 0.49.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has increased from -5.36 (Mar 24) to 0.00, marking an increase of 5.36.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 3.31 (Mar 24) to 0.00, marking a decrease of 3.31.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 105.36 (Mar 24) to 0.00, marking a decrease of 105.36.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 96.69 (Mar 24) to 0.00, marking a decrease of 96.69.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 3.56. This value is within the healthy range. It has increased from 2.82 (Mar 24) to 3.56, marking an increase of 0.74.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.35. This value is below the healthy minimum of 3. It has increased from 0.15 (Mar 24) to 1.35, marking an increase of 1.20.
• For Enterprise Value (Cr.), as of Mar 25, the value is 392.71. It has decreased from 401.68 (Mar 24) to 392.71, marking a decrease of 8.97.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.70. This value is below the healthy minimum of 1. It has decreased from 0.76 (Mar 24) to 0.70, marking a decrease of 0.06.
• For EV / EBITDA (X), as of Mar 25, the value is 6.72. This value is within the healthy range. It has decreased from 9.70 (Mar 24) to 6.72, marking a decrease of 2.98.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.41. This value is below the healthy minimum of 1. It has decreased from 0.46 (Mar 24) to 0.41, marking a decrease of 0.05.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 105.36 (Mar 24) to 0.00, marking a decrease of 105.36.
• For Price / BV (X), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 1. It has decreased from 0.86 (Mar 24) to 0.79, marking a decrease of 0.07.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.41. This value is below the healthy minimum of 1. It has decreased from 0.46 (Mar 24) to 0.41, marking a decrease of 0.05.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from -0.05 (Mar 24) to 0.03, marking an increase of 0.08.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness